MedTech POV with Scott Whitaker AdvaMed

Caroll Neubauer has a distinguished career in medtech, as the former long-time leader of B. Braun Medical Inc., now an adviser at Water Street Healthcare Partners, and co-chairman of The MedTech Conference Steering Committee. Caroll joined me on the Medtech POV podcast and previewed The MedTech Conference, Oct. 9-11, in Anaheim, California.

Dr. Peter Schneider, Professor of Surgery in the Division of Vascular & Endovascular Surgery at the University of California San Francisco, and Dr. Justin Klein, AdvaMed board member and co-founder at Vensana Capital joined AdvaMed's Scott Whitaker to talk about a recent New York Times story about atherectomies and peripheral artery disease (PAD) and the impact the story could have on patients seeking treatment for this condition.

AdvaMed President and CEO Scott Whitaker sits down for a wide-ranging discussion with Michael Minogue, former Chairman, President, and CEO of Abiomed. The lively conversation, encompassing Minogue’s military career to his decades of work in the medtech industry, highlights his entrepreneurial work ethic, leadership values, the lifesaving innovation the medtech industry is responsible for, and the ongoing work to help transitioning servicemembers find meaningful careers in the health care industry.

AdvaMed’s Scott Whitaker sits down on the latest episode of the MedTech POV podcast with Dr. Lucy Frasier to discuss the recent news about ethylene oxide (EtO), the real risks caused by the naturally occurring chemical, and what would happen to health care delivery if the chemical was banned as a sterilizer of medical devices and component parts.

Cary Vance, President and CEO of Titan Medical, joins AdvaMed’s Scott Whitaker to share his experience leading a small medical device company through the regulatory process as they transition from design to manufacturing.

Mick Farrell, ResMed CEO and member of the AdvaMed board of directors, joined AdvaMed’s Scott Whitaker on the MedTech POV podcast to discuss how an agile company with skilled staff and a clear mission can pivot sharply as the market demands, from scaling up ventilator production at the outset of the COVID-19 pandemic to informing semiconductor chips manufacturers of their product’s critical importance to the medical technology industry.